Pre-operative Ketorolac Administration Has no Pre-emptive Analgesic Effect Following Total Abdominal Hysterectomy
Status:
Completed
Trial end date:
2001-11-01
Target enrollment:
Participant gender:
Summary
Background: Experimental models using short duration noxious stimuli have led to the concept
of pre-emptive analgesia. Ketorolac, a non-steroidal anti-inflammatory drug (NSAID), has been
shown to have a post-operative narcotic sparing effect when given pre-operatively and
alternatively to not have this effect. This study was undertaken to determine whether a
single intravenous dose of ketorolac would result in decreased post-operative pain and
narcotic requirements.
Methods: In a double-blind, randomized controlled trial, 48 women undergoing abdominal
hysterectomy were studied. Patients in the ketorolac group received 30 mg of intravenous
ketorolac 30 minutes before surgical incision, while the control group received normal
saline. The post-operative analgesia was performed with a continuous infusion of tramadol at
12 mg/hour with the possibility of a 10 mg bolus every 10 minutes. Pain was assessed using
the Visual Analog Scale (VAS), tramadol consumption and hemodynamic parameters at 0, 1, 2, 4,
8, 12, 16 and 24 hours post-operatively. We quantified times to rescue analgesic (morphine),
adverse effects and patient satisfaction.